Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matucci

Showing results (221-230 of 295) with videos related to

Pageof 30
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|October 31, 2009
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic diseaseA Marchesoni, G Altomare, M Matucci-Cerinic, et al.
Therapeutics and Clinical Risk Management|January 11, 2020
It Is the Time to Think About a Treat-to-Target Strategy for Knee OsteoarthritisA Migliore, G Gigliucci, R J Petrella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Psoriatic disease: concepts and implicationsR Scarpa, G Altomare, A Marchesoni, et al.
Scandinavian Journal of Rheumatology|October 26, 2006
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytesM Cinelli, S Guiducci, A Del Rosso, et al.
Clinical and Experimental Rheumatology|September 8, 2006
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc?S Guiducci, C Fatini, A Georgountzos, et al.
The Journal of Pathology|August 19, 2006
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptorS Serratì, M Cinelli, F Margheri, et al.
Arthritis and Rheumatism|May 29, 2007
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosisP Cipriani, S Guiducci, I Miniati, et al.
Rheumatology (Oxford, England)|July 7, 2005
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytesA Del Rosso, M Cinelli, S Guiducci, et al.
Scandinavian Journal of Rheumatology|November 17, 2021
Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapyC Campochiaro, A Tomelleri, N Farina, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Efficacy of a tailored rehabilitation program for systemic sclerosisS Maddali Bongi, A Del Rosso, F Galluccio, et al.
Pageof 30

Showing results (221-230 of 295) with videos related to

Sort By:
Pageof 30
Journal of the European Academy of Dermatology and Venereology : JEADV|October 31, 2009
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic diseaseA Marchesoni, G Altomare, M Matucci-Cerinic, et al.
Therapeutics and Clinical Risk Management|January 11, 2020
It Is the Time to Think About a Treat-to-Target Strategy for Knee OsteoarthritisA Migliore, G Gigliucci, R J Petrella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Psoriatic disease: concepts and implicationsR Scarpa, G Altomare, A Marchesoni, et al.
Scandinavian Journal of Rheumatology|October 26, 2006
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytesM Cinelli, S Guiducci, A Del Rosso, et al.
Clinical and Experimental Rheumatology|September 8, 2006
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc?S Guiducci, C Fatini, A Georgountzos, et al.
The Journal of Pathology|August 19, 2006
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptorS Serratì, M Cinelli, F Margheri, et al.
Arthritis and Rheumatism|May 29, 2007
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosisP Cipriani, S Guiducci, I Miniati, et al.
Rheumatology (Oxford, England)|July 7, 2005
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytesA Del Rosso, M Cinelli, S Guiducci, et al.
Scandinavian Journal of Rheumatology|November 17, 2021
Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapyC Campochiaro, A Tomelleri, N Farina, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Efficacy of a tailored rehabilitation program for systemic sclerosisS Maddali Bongi, A Del Rosso, F Galluccio, et al.
Pageof 30